Experts and former FDA staff call for reforms to FDA's National Priority Voucher program at public hearing
By
Rowan Walrath
Sesame, salt, and substance. A flagship bake.
Summary
Experts and former FDA staffers testified at a public hearing calling for significant reforms to the FDA's Commissioner's National Priority Voucher (CNPV) program, which was established under former FDA commissioner Makary. The program faces criticism from multiple stakeholders including pharma companies and advocates who weighed in during the hearing.
Key quotes
· 1 pulledThe US Food and Drug Administration needs to make some serious changes to its Commissioner's National Priority Voucher (CNPV) program, according to several experts and former FDA staffers who testified during a public hearing Thursday.
You might also wanna read
FDA Drug Regulator Accused of Targeting Former Business Associate's Pharmaceutical Company
The article discusses a scandal at the FDA involving a top drug regulator who allegedly used his position to target a former business associ
arstechnica.com·7mo ago
FDA Official Requests Removal of YouTube Videos Showing His COVID Vaccine Criticism
A top FDA official, Vinay Prasad, demanded YouTube remove videos of himself criticizing COVID-19 vaccines from a physician's channel. Jonath
theguardian.com·9mo ago
Collapse of the FDA Under New Health Secretary
The article discusses the collapse of the FDA under the new health secretary, Robert F. Kennedy Jr., who is accused of dismantling the agenc
nytimes.com·10mo ago
FDA Approves First Dual-AAV Gene Therapy for Genetic Hearing Loss Under Priority Voucher Program
The FDA has approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy for trea
FDA·1mo ago
FDA Issues Refusal-to-File Letter to Moderna for mRNA Influenza Vaccine
The article criticizes the FDA's recent actions under the new administration, particularly focusing on a Refusal-to-File (RTF) letter issued
marginalrevolution.com·3mo ago